nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—MMP13—degenerative disc disease	0.0649	0.0649	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—COL9A3—degenerative disc disease	0.0532	0.0532	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—ADAMTS5—degenerative disc disease	0.0532	0.0532	CbGpPWpGaD
Bortezomib—CTSG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.0522	0.0522	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—ADAMTS4—degenerative disc disease	0.0453	0.0453	CbGpPWpGaD
Bortezomib—CTSG—Activation of Matrix Metalloproteinases—MMP3—degenerative disc disease	0.0434	0.0434	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—COL9A2—degenerative disc disease	0.0416	0.0416	CbGpPWpGaD
Bortezomib—CTSG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.0349	0.0349	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—MMP13—degenerative disc disease	0.0286	0.0286	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—GDF5—degenerative disc disease	0.0279	0.0279	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.0223	0.0223	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—COL9A3—degenerative disc disease	0.0223	0.0223	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.0223	0.0223	CbGpPWpGaD
Bortezomib—CTSG—Degradation of the extracellular matrix—MMP3—degenerative disc disease	0.0192	0.0192	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.019	0.019	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—COL9A2—degenerative disc disease	0.0174	0.0174	CbGpPWpGaD
Bortezomib—PSMD1—Parkin-Ubiquitin Proteasomal System pathway—PARK2—degenerative disc disease	0.016	0.016	CbGpPWpGaD
Bortezomib—PSMD2—Parkin-Ubiquitin Proteasomal System pathway—PARK2—degenerative disc disease	0.0159	0.0159	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—MMP13—degenerative disc disease	0.012	0.012	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—BMP2—degenerative disc disease	0.0116	0.0116	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—ADAMTS5—degenerative disc disease	0.0104	0.0104	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—ADAMTS3—degenerative disc disease	0.0104	0.0104	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism of mRNA—RPL34—degenerative disc disease	0.00906	0.00906	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism of mRNA—RPL34—degenerative disc disease	0.00901	0.00901	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism of mRNA—RPL34—degenerative disc disease	0.00897	0.00897	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—RPL34—degenerative disc disease	0.00887	0.00887	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—ADAMTS4—degenerative disc disease	0.00887	0.00887	CbGpPWpGaD
Bortezomib—CTSG—Extracellular matrix organization—MMP3—degenerative disc disease	0.00803	0.00803	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism of RNA—RPL34—degenerative disc disease	0.00775	0.00775	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism of RNA—RPL34—degenerative disc disease	0.00771	0.00771	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism of RNA—RPL34—degenerative disc disease	0.00768	0.00768	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism of mRNA—RPL34—degenerative disc disease	0.00686	0.00686	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism of mRNA—RPL34—degenerative disc disease	0.00686	0.00686	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism of mRNA—RPL34—degenerative disc disease	0.00686	0.00686	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism of mRNA—RPL34—degenerative disc disease	0.00677	0.00677	CbGpPWpGaD
Bortezomib—PSMA1—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.00672	0.00672	CbGpPWpGaD
Bortezomib—PSMD1—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.00669	0.00669	CbGpPWpGaD
Bortezomib—PSMD2—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.00666	0.00666	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism of RNA—RPL34—degenerative disc disease	0.00587	0.00587	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism of RNA—RPL34—degenerative disc disease	0.00587	0.00587	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism of RNA—RPL34—degenerative disc disease	0.00587	0.00587	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism of RNA—RPL34—degenerative disc disease	0.00579	0.00579	CbGpPWpGaD
Bortezomib—PSMA1—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00577	0.00577	CbGpPWpGaD
Bortezomib—PSMD1—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00574	0.00574	CbGpPWpGaD
Bortezomib—PSMD2—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00571	0.00571	CbGpPWpGaD
Bortezomib—PSMB5—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0051	0.0051	CbGpPWpGaD
Bortezomib—PSMB1—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0051	0.0051	CbGpPWpGaD
Bortezomib—PSMB2—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.0051	0.0051	CbGpPWpGaD
Bortezomib—PSMB8—Antigen processing: Ubiquitination & Proteasome degradation—PARK2—degenerative disc disease	0.00502	0.00502	CbGpPWpGaD
Bortezomib—CYP1A1—Metapathway biotransformation—CHST3—degenerative disc disease	0.00469	0.00469	CbGpPWpGaD
Bortezomib—PSMB2—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00437	0.00437	CbGpPWpGaD
Bortezomib—PSMB1—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00437	0.00437	CbGpPWpGaD
Bortezomib—PSMB5—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00437	0.00437	CbGpPWpGaD
Bortezomib—PSMB8—Class I MHC mediated antigen processing & presentation—PARK2—degenerative disc disease	0.00431	0.00431	CbGpPWpGaD
Bortezomib—CYP2C8—Metapathway biotransformation—CHST3—degenerative disc disease	0.0043	0.0043	CbGpPWpGaD
Bortezomib—CYP2C19—Metapathway biotransformation—CHST3—degenerative disc disease	0.00384	0.00384	CbGpPWpGaD
Bortezomib—CYP2D6—Metapathway biotransformation—CHST3—degenerative disc disease	0.00353	0.00353	CbGpPWpGaD
Bortezomib—CYP2C9—Metapathway biotransformation—CHST3—degenerative disc disease	0.0035	0.0035	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CHST3—degenerative disc disease	0.00348	0.00348	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CHST3—degenerative disc disease	0.00346	0.00346	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CHST3—degenerative disc disease	0.00345	0.00345	CbGpPWpGaD
Bortezomib—CYP1A2—Metapathway biotransformation—CHST3—degenerative disc disease	0.00299	0.00299	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CHST3—degenerative disc disease	0.00292	0.00292	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CHST3—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CHST3—degenerative disc disease	0.00289	0.00289	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—PARK2—degenerative disc disease	0.00285	0.00285	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—PARK2—degenerative disc disease	0.00284	0.00284	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—PARK2—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CHST3—degenerative disc disease	0.00264	0.00264	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CHST3—degenerative disc disease	0.00264	0.00264	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CHST3—degenerative disc disease	0.00264	0.00264	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CHST3—degenerative disc disease	0.0026	0.0026	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—RPL34—degenerative disc disease	0.00242	0.00242	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—RPL34—degenerative disc disease	0.0024	0.0024	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—RPL34—degenerative disc disease	0.00239	0.00239	CbGpPWpGaD
Bortezomib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.00231	0.00231	CbGpPWpGaD
Bortezomib—PSMA1—Disease—RPL34—degenerative disc disease	0.00224	0.00224	CbGpPWpGaD
Bortezomib—PSMD1—Disease—RPL34—degenerative disc disease	0.00223	0.00223	CbGpPWpGaD
Bortezomib—PSMD2—Disease—RPL34—degenerative disc disease	0.00222	0.00222	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CHST3—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CHST3—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CHST3—degenerative disc disease	0.00221	0.00221	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CHST3—degenerative disc disease	0.00218	0.00218	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—PARK2—degenerative disc disease	0.00216	0.00216	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—PARK2—degenerative disc disease	0.00216	0.00216	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—PARK2—degenerative disc disease	0.00216	0.00216	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—PARK2—degenerative disc disease	0.00213	0.00213	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—COL9A3—degenerative disc disease	0.00185	0.00185	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—COL9A3—degenerative disc disease	0.00184	0.00184	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—RPL34—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—RPL34—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—RPL34—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—COL9A3—degenerative disc disease	0.00183	0.00183	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—RPL34—degenerative disc disease	0.00181	0.00181	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—PARK2—degenerative disc disease	0.00173	0.00173	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—PARK2—degenerative disc disease	0.00172	0.00172	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—PARK2—degenerative disc disease	0.00172	0.00172	CbGpPWpGaD
Bortezomib—PSMB2—Disease—RPL34—degenerative disc disease	0.0017	0.0017	CbGpPWpGaD
Bortezomib—PSMB5—Disease—RPL34—degenerative disc disease	0.0017	0.0017	CbGpPWpGaD
Bortezomib—PSMB1—Disease—RPL34—degenerative disc disease	0.0017	0.0017	CbGpPWpGaD
Bortezomib—PSMB8—Disease—RPL34—degenerative disc disease	0.00168	0.00168	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—COL9A2—degenerative disc disease	0.00144	0.00144	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—COL9A2—degenerative disc disease	0.00144	0.00144	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—COL9A2—degenerative disc disease	0.00143	0.00143	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—COL9A3—degenerative disc disease	0.0014	0.0014	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—COL9A3—degenerative disc disease	0.0014	0.0014	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—COL9A3—degenerative disc disease	0.0014	0.0014	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—COL9A3—degenerative disc disease	0.00138	0.00138	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—PARK2—degenerative disc disease	0.00131	0.00131	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—PARK2—degenerative disc disease	0.00131	0.00131	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—PARK2—degenerative disc disease	0.00131	0.00131	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—PARK2—degenerative disc disease	0.00129	0.00129	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CHST3—degenerative disc disease	0.00116	0.00116	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—COL9A2—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—COL9A2—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—COL9A2—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—COL9A2—degenerative disc disease	0.00108	0.00108	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—BMP2—degenerative disc disease	0.00096	0.00096	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—BMP2—degenerative disc disease	0.000955	0.000955	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—BMP2—degenerative disc disease	0.000951	0.000951	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CHST3—degenerative disc disease	0.000814	0.000814	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CHST3—degenerative disc disease	0.000746	0.000746	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—BMP2—degenerative disc disease	0.000727	0.000727	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—BMP2—degenerative disc disease	0.000727	0.000727	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—BMP2—degenerative disc disease	0.000727	0.000727	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—BMP2—degenerative disc disease	0.000717	0.000717	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CHST3—degenerative disc disease	0.000666	0.000666	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP3—degenerative disc disease	0.000665	0.000665	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP3—degenerative disc disease	0.000662	0.000662	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP3—degenerative disc disease	0.000659	0.000659	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CHST3—degenerative disc disease	0.000613	0.000613	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CHST3—degenerative disc disease	0.000607	0.000607	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CHST3—degenerative disc disease	0.000519	0.000519	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP3—degenerative disc disease	0.000504	0.000504	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP3—degenerative disc disease	0.000504	0.000504	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP3—degenerative disc disease	0.000504	0.000504	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP3—degenerative disc disease	0.000497	0.000497	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000401	0.000401	CbGpPWpGaD
